Evidence map›Paper›PMID 40318862›Full record

ArticleSexually transmitted infections2025

Development of machine learning-based mpox surveillance models in a learning health system.

Harry Reyes Nieva, Jason Zucker, Emma Tucker, Jacob McLean, Clare DeLaurentis, Shauna Gunaratne, Noémie Elhadad

Abstract read
In one paragraph

Article in Sexually transmitted infections, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Harry Reyes NievaDepartment of Biomedical Informatics, Columbia University, New York, New York, USA harry.reyes@columbia.edu.ORCID http://orcid.org/0000-0001-7774-2561
Jason ZuckerDepartment of Biomedical Informatics, Columbia University, New York, New York, USA.ORCID http://orcid.org/0000-0001-6987-6412
Emma TuckerVagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
Jacob McLeanDivision of Infectious Diseases, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
Clare DeLaurentisDivision of Infectious Diseases, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
Shauna GunaratneDivision of Infectious Diseases, NewYork-Presbyterian Hospital/Columbia University Irving Medical Center, New York, New York, USA.
Noémie ElhadadDepartment of Biomedical Informatics, Columbia University, New York, New York, USA.

Funding

Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials UnitUM1AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK · 2012 to 2026
$44.8M
Training in Biomedical Informatics at Columbia UniversityT15LM007079 · NLM · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI NOEMIE ELHADAD, GEORGE M HRIPCSAK · 1992 to 2026
$28.9M
Columbia Collaborative HIV/AIDS Clinical Trials UnitU01AI069470 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI HAMMER, SCOTT M · 2007 to 2011
$15.4M
Columbia Integrated Training Program in Infectious Diseases ResearchT32AI100852 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI MAGDALENA ELZBIETA SOBIESZCZYK, Anne-Catrin Uhlemann · 2013 to 2026
$2.2M
Harnessing Bioinformatics for HIV Prevention: Understanding Persistence in Comprehensive HIV Prevention ServicesK23AI150378 · NIAID · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZUCKER, JASON · 2020 to 2024
$960k
NIAID NIH HHS K23 AI150378NIAID NIH HHS T32 AI100852NIAID NIH HHS U01 AI069470NIAID NIH HHS UM1 AI069470NLM NIH HHS T15 LM007079
6 · The paper itself

Abstract

objectivesThis study aimed to develop robust machine learning (ML)-based and deep learning (DL)-based models capable of detecting mpox cases for surveillance efforts using clinical notes.

methodsAs part of a learning health system initiative, we conducted a retrospective study of clinical encounters at the Columbia University Irving Medical Center in New York City. We included patients with mpox diagnoses confirmed by PCR testing between 15 May 2022 and 15 October 2022 and three matched controls for each case based on patient age, sex, race, ethnicity and visit month. We trained three mpox surveillance models using: (1) logistic regression with L1 regularisation (least absolute shrinkage and selection operator (LASSO)), (2) ClinicalBERT and (3) ClinicalLongformer. We evaluated model performance using precision, recall, F1 score, area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC) and recall at 80% precision (RP80).

resultsThe study included 228 PCR-confirmed mpox cases and 698 controls. LASSO regression outperformed the DL models with a precision, recall and F1 score of 0.93, AUROC of 0.97, AUPRC of 0.93 and RP80 of 0.89. ClinicalBERT achieved a precision of 0.88, recall of 0.89, F1 score of 0.88 and AUROC of 0.93. ClinicalLongformer achieved a precision of 0.87, recall of 0.88, F1 score of 0.87 and AUROC of 0.92. Phrases related to symptoms (eg, lesions and pain) were among the most predictive features in LASSO regression.

conclusionsML and DL models based on clinical notes show promise for identifying mpox cases. In this study, LASSO regression outperformed DL models and excelled in minimising false positives. These findings highlight the potential for ML and DL methods to support case surveillance for mpox and other infectious diseases. These methods may also prove helpful for flagging missed or delayed diagnoses as part of continuous quality improvement.

Indexed as

Machine LearningMpox, MonkeypoxAdolescentAdultDeep LearningFemaleHumansLogistic ModelsMaleMiddle AgedNew York CityRetrospective StudiesYoung AdultDisease Transmission, InfectiousINFORMATION TECHNOLOGYPopulation Surveillance

Identifiers

PMID40318862
PMCPMC12353557

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.